Jakob R. Passweg
Elite in Anemia

Jakob R. Passweg

Basel, BS, CH 
Clinical Trials:Currently Recruiting for 1 Trial
Elite in Anemia
Basel, BS, CH 
OverviewLocationsClinical Research

Overview

Jakob Passweg practices in Basel, Switzerland. Mr. Passweg is rated as an Elite expert by MediFind in the treatment of Anemia. His top areas of expertise are Aplastic Anemia, Graft Versus Host Disease (GvHD), Leukemia, Bone Marrow Transplant, and Bone Graft.

His clinical research consists of co-authoring 469 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 62 articles in the study of Anemia.

Gender
Male

Locations

Basel, BS, Switzerland
Other Locations
Zurich, ZH, Switzerland
Bern, BE, Switzerland
Geneve, GE, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase I/II Single Center Study to Assess the Safety, Tolerability and Feasibility of Pre-emptive Immunotherapy With in Vitro Expanded Natural Killer Cells in Patients Treated With Haplo-HSCT for AML/MDS
A Phase I/II Single Center Study to Assess the Safety, Tolerability and Feasibility of Pre-emptive Immunotherapy With in Vitro Expanded Natural Killer Cells in Patients Treated With Haplo-HSCT for AML/MDS
Enrollment Status: Recruiting
Publish Date: May 29, 2024
Intervention Type: Other
Study Phase: Phase 1/Phase 2
The Skin Microbiome in Graft Versus Host Disease Dynamics of the Skin-microbiota After Allogeneic Stem Cell Transplantation - a Predictive Marker for Graft Versus Host Disease?
The Skin Microbiome in Graft Versus Host Disease Dynamics of the Skin-microbiota After Allogeneic Stem Cell Transplantation - a Predictive Marker for Graft Versus Host Disease?
Enrollment Status: Active_not_recruiting
Publish Date: April 03, 2025
Intervention Type: Diagnostic test
A Phase I/II Single Center Study to Assess Tolerability and Feasibility of Infusions of Allogeneic Expanded Haploidentical Natural Killer (NK) Cells in Patients Treated With High Dose Melphalan Chemotherapy and Autologous Stem Cell Transplantation for a Multiple Myeloma
A Phase I/II Single Center Study to Assess Tolerability and Feasibility of Infusions of Allogeneic Expanded Haploidentical Natural Killer (NK) Cells in Patients Treated With High Dose Melphalan Chemotherapy and Autologous Stem Cell Transplantation for a Multiple Myeloma
Enrollment Status: Completed
Publish Date: April 04, 2023
Intervention Type: Other
Study Phase: Phase 1/Phase 2
Cyclophosphamide-Busulfan Versus Busulfan-Cyclophosphamide as Conditioning Regimen Before Allogeneic Hematopoietic Stem Cell Transplantation for Leukemia: a Prospective Randomized Study to Assess Liver Toxicity
Cyclophosphamide-Busulfan Versus Busulfan-Cyclophosphamide as Conditioning Regimen Before Allogeneic Hematopoietic Stem Cell Transplantation for Leukemia: a Prospective Randomized Study to Assess Liver Toxicity
Enrollment Status: Completed
Publish Date: March 02, 2018
Intervention Type: Drug
Study Phase: Not Applicable
View 3 Less Clinical Trials

469 Total Publications

Exacerbation of demyelinating polyneuropathy after adoptive cell therapy with tumour-infiltrating lymphocytes by metastatic melanoma.
Exacerbation of demyelinating polyneuropathy after adoptive cell therapy with tumour-infiltrating lymphocytes by metastatic melanoma.
Journal: Swiss medical weekly
Published: October 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Passweg's expertise for a condition
ConditionClose
View All 13 Advanced Conditions
View All 44 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile